CeriBell, Inc. (CBLL)
NASDAQ • Healthcare
Last close at September 9, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, CeriBell, Inc. currently loses $69.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 3
in 54 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
About CeriBell, Inc.
CeriBell, Inc. trades on the NASDAQ as CBLL and makes neurodiagnostic equipment for the healthcare market, centered on AI-powered electroencephalography used at the patient's bedside. In FY2025, the company generated $89.1 million in revenue from its platform, accessories, and related devices for immediate diagnosis and treatment of neurological conditions.
Today's Snapshot
CBLL opened 1.1% below yesterday's close, while its sector was flat.
Trading Volume
Below 10d avg (267.2K)
45.5K
vs S&P 500 Today
Underperforming Market
-2.22%
Updated: September 10, 2026 at 15:11 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$19.10 - $24.14Buy
- RSI (14)57.20Neutral
- Stochastic %K (14, 3, 3)53.53Neutral
- MACD Level (12, 26)1.00Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.